Zimmer Biomet Cash Flow Statement
NYSE: ZBHHealth CareIndustrial SpecialtiesUSD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Zimmer Biomet free cash flow
In fiscal 2025, Zimmer Biomet generated $1.70 billion of operating cash flow and spent $224.5 million on capital expenditures. That left free cash flow of $1.47 billion, a free-cash-flow margin of 17.9% of revenue. Free cash flow was up 13.7% from the prior year's $1.30 billion.
Zimmer Biomet returned $677.3 million to shareholders: $190.3 million in dividends and $487.0 million in share repurchases, equal to 46% of free cash flow. Free cash flow covered dividend payments 7.7 times.
Summary generated from market data by MetaCap's automated system. Methodology
Zimmer Biomet cash flow statement (annual)
| Fiscal year (USD) | FY 20252025-12-31 | FY 20242024-12-31 | FY 20232023-12-31 | FY 20222022-12-31 | FY 20212021-12-31 | FY 20202020-12-31 | FY 20192019-12-31 | FY 20182018-12-31 | FY 20172017-12-31 | FY 20162016-12-31 |
|---|---|---|---|---|---|---|---|---|---|---|
| Net Income | 705.10M | 905.30M | 1.03B | 232.40M | 402.10M | -137.40M | 1.13B | -379.30M | 1.81B | 304.60M |
| Net Income growth (YoY) | -22.11% | -11.69% | +341.09% | -42.20% | — | -112.14% | — | -120.92% | +495.34% | +108.34% |
| Depreciation & Amortization | 1.09B | 996.30M | 951.70M | 926.40M | 937.70M | 898.40M | 1.01B | 1.04B | 1.06B | 1.04B |
| Stock-Based Compensation | 90.20M | 101.00M | 99.80M | 105.00M | 76.00M | 73.80M | 84.30M | 65.50M | 53.70M | 57.30M |
| Change in Working Capital | 72.70M | -361.80M | -347.60M | -157.30M | 37.30M | -197.00M | -261.00M | 170.00M | -91.70M | -31.10M |
| Operating Cash Flow | 1.70B | 1.50B | 1.58B | 1.36B | 1.50B | 1.20B | 1.59B | 1.75B | 1.58B | 1.63B |
| Capital Expenditures | -224.50M | -203.80M | -291.10M | -187.90M | -143.60M | -111.90M | -207.10M | -162.70M | -156.00M | -184.70M |
| Investing Cash Flow | -1.98B | -888.10M | -778.90M | -522.00M | -503.60M | -613.80M | -729.30M | -416.60M | -510.80M | -1.69B |
| Dividends Paid | -190.30M | -196.00M | -200.90M | -201.20M | -200.10M | -198.50M | -196.70M | -195.20M | -193.60M | -188.40M |
| Share Repurchases | -487.00M | -868.00M | -692.20M | -126.40M | — | — | — | — | — | -415.50M |
| Debt Issued | 2.49B | 1.44B | 499.80M | — | 1.60B | 1.50B | 549.20M | 749.50M | 192.70M | 750.00M |
| Debt Repaid | — | 0 | -33.90M | -242.90M | — | — | -960.00M | -1.43B | -940.00M | -800.00M |
| Financing Cash Flow | 326.00M | -484.50M | -763.50M | -775.70M | -1.31B | -421.80M | -779.90M | -1.30B | -1.21B | -743.20M |
| Net Change in Cash | 66.40M | 109.70M | 40.10M | -102.80M | -323.60M | 184.20M | 75.10M | 18.40M | -109.70M | -825.20M |
| Free Cash Flow | 1.47B | 1.30B | 1.29B | 1.17B | 1.36B | 1.09B | 1.38B | 1.58B | 1.43B | 1.45B |
This table shows 10 annual periods of Zimmer Biomet's cash flow statement, from FY 2025 back to FY 2016, across 14 line items including net income, depreciation & amortization, stock-based compensation. Values in USD; B = billions, M = millions. Fiscal periods follow ZBH's reporting calendar. What is a cash flow statement?